🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Personalization of Visual Characters and Text-to-Speech (TTS) to Support Learning in Students With Reading Difficulties

RecruitingNAAges 7 Years - 15 YearsAllIRCCS Eugenio Medea
NCT06947512 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Previous research has shown the importance of font type, size and spacing to facilitate text reading in dyslexia. A special automatized procedure was designed to select the most favorable parameters for both text visualization and text-to-speech (TTS) conversion to be used by students with reading difficulties. The validation of its outcomes will be carried out through a systematic comparison of the use of the personalized versus standard fonts and voices in reading and writing tests.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria (for TD group): * age 7-15 years * no history of reading difficulties * attends school in Italy Exclusion Criteria (for TD group): * special educational needs or diagnosis of neurodevelopmental disorders Inclusion Criteria (for DD group): * age 7-15 years * diagnosis of Developmental Dyslexia or Specific Reading Disorder * Attends school in Italy Exclusion Criteria (for DD group): * diagnosis of Intellectual Disability Inclusion Criteria (for SEN group): * age 7-15 years * reported by school to have significant difficulties in reading and writing * Attends school in Italy (at least 6 months continued schooling and exposure to the Italian language) Exclusion Criteria (for SEN group): * diagnosis of Intellectual Disability
💊

What it tests

  • Seleggo Test
📍

Where

3 sites
IRCCS E. Medea, polo di Bosisio Parini
Bosisio Parini, Italy
IRCCS E.Medea, polo di Conegliano
Conegliano, Italy
Associazione La Nostra Famiglia
Treviso, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy